Alan Meds vs Zeuss
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Zeuss
Best for Buyers who actively dislike subscription auto-renewals and want a one-time-purchase model for compounded GLP-1 or GIP/GLP-1 — the only provider in the WLR directory offering this billing model. Strong fit for cost-conscious patients who want bundled transparency (provider review + meds + cold-chain shipping + delivery for $125-$175) and the option to order only when needed.Starting at $125/mo
Side-by-Side Comparison
| Feature | Alan Meds | Zeuss |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.0/10 |
| Starting Price | ✓$99/mo | $125/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.5 ★ /5 |
| Features | 5 features | ✓10 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Zeuss
Pros
- ✓**No-subscription / one-time-purchase model is genuinely differentiated** — every other DTC GLP-1 competitor in the WLR directory uses monthly subscriptions with auto-renewal. Zeuss's 'pay only for the care you need' framing is unique.
- ✓Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- ✓Both 503A AND 503B compounding pathways explicitly mentioned — uncommon transparency
- ✓Bundled pricing structure includes everything (provider review + meds + cold-chain shipping + delivery) — no hidden fees framing
- ✓Full refund if physician cannot prescribe — reduces sign-up risk
- ✓$125/mo GLP-1 starting price is competitive with the broader DTC market
- ✓Cold-chain temperature-controlled shipping disclosed (uncommon detail)
- ✓Gender-segmented Body services accommodate buyers who prefer male-focused or female-focused clinical framing
Cons
- ✗Specific 503A pharmacy partner NOT named (only generic '503A and 503B state-licensed compounding pharmacies' framing)
- ✗LegitScript certification NOT mentioned on homepage or Body pages
- ✗Named medical director / physician leadership NOT disclosed
- ✗Full states-served list NOT disclosed (only 'US-licensed physicians' generic)
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed in footer
- ✗Governing law / arbitration venue NOT disclosed
- ✗Subpath /body, /weight-loss return 404 — actual GLP-1 pages are at /services/body-for-him/ and /services/body-for-her/ (slightly awkward URL structure)
- ✗Site is JS-rendered SPA — content captured only via Chrome MCP, not WebFetch
- ✗Specific corporate physical address NOT disclosed in footer
- ✗$125 / $175 'starting at' framing suggests pricing may step up at higher dose tiers but tier structure not detailed on the public page
Our Verdict
Alan Meds edges out Zeuss with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Zeuss remains a solid alternative, especially if you're looking for Buyers who actively dislike subscription auto-renewals and want a one-time-purchase model for compounded GLP-1 or GIP/GLP-1 — the only provider in the WLR directory offering this billing model. Strong fit for cost-conscious patients who want bundled transparency (provider review + meds + cold-chain shipping + delivery for $125-$175) and the option to order only when needed..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.